Blog

Quick answer: Before you can submit an NIH SBIR or STTR proposal, your company must complete a chain of federal registrations: SAM.gov (which issues your UEI), a CAGE code, SBIR.gov, the SBA Company Registry (which issues your SBC Control ID), Grants.gov, SciENcv for all biosketches, and eRA Commons accounts for your Signing Official and Principal Investigator. Several depend on earlier ones, so the order matters. The full sequence typically takes about a month, so start the

Quick answer: Most failed first-time SBIR applications fail for reasons unrelated to the science. The ten recurring mistakes are: (1) waiting until the last minute, (2) delaying required registrations like SAM.gov and eRA Commons, (3) writing before setting a strategy, (4) treating the application as either an academic proposal or a VC pitch, (5) skipping customer discovery, (6) ignoring the review criteria, (7) underestimating commercialization in Phase I, (8) assuming AI pr

Quick answer: After a decade working with founders on non-dilutive funding, the most common bottleneck is not the market, the competition, or the product. It is the founder. Ten traits quietly limit brilliant people: (1) ego that shows up as defensiveness, (2) talking too much and listening too little, (3) needing to be right instead of learning, (4) trying to do everything alone, (5) lack of focus, (6) perfectionism disguised as productivity, (7) avoiding difficult conversat

Quick answer: An SBIR budget has three parts. Direct costs are expenses tied directly to the work, such as salaries, supplies, consultants, subcontractors, travel, and equipment, and they typically account for roughly 80% of the budget. Indirect costs are the overhead that keeps the company running, such as rent, utilities, insurance, and administration, usually calculated as 20% to 40% of direct costs, or higher with a negotiated rate. The small business fee is a profit allo

Quick answer: The most damaging SBIR advice circulating in 2026 is convincing precisely because it sounds reasonable. Eight myths cost founders the most funding: (1) let AI write your proposal, (2) hire a grant writer and you are done, (3) commercialization does not matter in Phase I, (4) great technology sells itself, (5) SBIR is mostly luck, (6) you need mountains of preliminary data to apply, (7) recruit a famous professor or politician and you are funded, and (8) if rejec

Quick answer: Since the SBIR Reauthorization Act passed, founders keep asking the same ten questions. The short answers: (1) do not skip this cycle, waiting usually puts you in a more competitive field; (2) timing is now agency-specific, with NSF already back; (3) the backlog and rollover funding may crowd FY2027 rather than thin it; (4) venture backing does not disqualify you if you show federal dollars cover distinct technical risk; (5) most rejections come from administrat

Most founders assume NIH made a few routine edits to its solicitation for the September 2026 cycle. That assumption is wrong, and it is expensive. A close read of the new omnibus shows something closer to a full rewrite. Several of the changes can disqualify an application automatically, over issues a founder may not even know exist. Below are the ten biggest changes, in plain English, and what each one means for your funding strategy in 2026 and beyond. One note on terminolo

Quick answer: The NSF SBIR program is back with roughly $200 million in non-dilutive funding, but the Reauthorization Act rewrote the rules. The seven changes that matter most in 2026 are: (1) a full commercialization award ladder from Phase I through the new Strategic Breakthrough award, (2) Phase I budgets up to $305,000 and Phase II up to $1.25 million, (3) a hard cap of two Project Pitches per company per year, (4) a positioning shift away from broadening-participation la

If you're a founder raising capital in 2026, there's a question worth asking before you take a single VC meeting: why are you diluting your startup when there's $4 billion in non-dilutive funding sitting on the table? Most early-stage teams have never heard of the SBIR program. That's wild — because it's one of the largest sources of startup capital in the country, and it's specifically designed for the companies VCs are too cautious to back. This guide breaks down exactly wh

The SBIR program went silent on September 1, 2025. With the Small Business Innovation and Economic Security Act (SBIESA) finally signed in April 2026, one of the largest non-dilutive funding channels for deep tech and scientific founders is back open. But what most founders don't realize is that the bar has moved up considerably — and the founders who rush in without adapting will burn their shot fast. There is more SBIR funding available than ever, with some awards now reach

The Department of Energy moved SBIR/STTR under the Office of Technology Commercialization. This is no longer just a research grant — it's a commercialization engine. Here are the 9 changes every energy and climate tech founder needs to understand. The U.S. Department of Energy has consolidated SBIR/STTR management under the Office of Technology Commercialization — and the implications for founders are significant. This isn't a minor administrative change. It signals a funda

The U.S. Department of Energy has consolidated SBIR/STTR management under the Office of Technology Commercialization (OTC) — and the implications for founders are significant. This isn't a minor administrative change. It signals a fundamental shift in what DOE is looking for, how proposals are evaluated, and what it takes to win. Climate tech, energy systems, AI, quantum, and semiconductor founders who apply under the old assumptions will get filtered out fast. There is more

The ARPA-H SBIR program offers small businesses non-dilutive funding of up to $600,000 for Phase 1 and $3.5 million for Phase 2 to develop breakthrough health technologies. Run by the Advanced Research Projects Agency for Health (ARPA-H), it features a faster, more streamlined review process than traditional federal funding pathways — and a new solicitation is opening with a target date of June 11, 2026. If you're a U.S.-based small business working on transformative healthca

The five-year SBIR/STTR reauthorization is now law — and it brings some of the most significant changes the program has seen in years. From the new Strategic Breakthrough Award track offering up to $30M in sequential Phase II funding, to the expansion of Direct to Phase II (D2P2) into STTR, to tighter foreign-affiliation due diligence, the rules of engagement for small businesses working with the Department of the Air Force (DAF) and the U.S. Space Force are evolving fast. Th

If you're a startup founder preparing for SBIRs or federal R&D funding in 2026, you are about to get pitched — hard. Every consultant and agency is gearing up for the same thing: to sell you. With the SBIR program back online, the grant writing industry is mobilizing fast — and a lot of bad players are optimizing for one outcome: getting you to sign, not getting you funded. This is a $6 billion market. Everyone suddenly “wins grants” and has a “proven system.” But here's the